Pathogenicity and virulence of Hepatitis B virus

References

• Blumberg BS. A new antigen in leukemia sera. Jama. 1965;191(7):541–546.
   PubMed Web of Science ®Google Scholar
• Dane D, Cameron C, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970;295(7649):695–698.
   Google Scholar
• Almeida JD, Waterson A, Trowell JM, et al. The finding of virus-like particles in two Australian-antigen-positive human livers. Microbios. 1970;2(6):145–153.
   Google Scholar
• Almeida J, Rubenstein D, Stott E. New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet. 1971;298(7736):1225–1227.
   Google Scholar
• Kaplan PM, Greenman RL, Gerin JL, et al. DNA polymerase associated with human hepatitis B antigen. J Virol. 1973;12(5):995–1005.
   PubMed Web of Science ®Google Scholar
• Robinson WS, Clayton DA, Greenman RL. DNA of a human hepatitis B virus candidate. J Virol. 1974;14(2):384–391.
   PubMed Web of Science ®Google Scholar
• Landers TA, Greenberg HB, Robinson WS. Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol. 1977;23(2):368–376.
   PubMed Web of Science ®Google Scholar
• Albin C, Robinson WS. Protein kinase activity in hepatitis B virus. J Virol. 1980;34(1):297–302.
   PubMed Web of Science ®Google Scholar
• Crowther R, Kiselev N, Böttcher B, et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell. 1994;77(6):943–950. DOI:10.1016/0092-8674(94)90142-2.
   PubMed Web of Science ®Google Scholar
• Hu J, Liu K. Complete and incomplete hepatitis B virus particles: formation, function, and application. Viruses. 2017;9(3):56.
   PubMed Web of Science ®Google Scholar
• Rydell GE, Prakash K, Norder H, et al. Hepatitis B surface antigen on subviral particles reduces the neutralizing effect of anti-HBs antibodies on hepatitis B viral particles in vitro. Virology. 2017;509:67–70.
   PubMed Web of Science ®Google Scholar
• Kaplan P, Ford E, Purcell R, et al. Demonstration of subpopulations of Dane particles. J Virol. 1976;17(3):885–893.
   PubMed Web of Science ®Google Scholar
• Possehl C, Repp R, Heermann K-H, et al. Absence of free core antigen in anti-HBc negative viremic hepatitis B carriers. Arch Virol Suppl. Springer; 1992. p. 39–41.
   Google Scholar
• Summers J, O’Connell A, Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Nat Acad Sci. 1975;72(11):4597–4601.
   PubMed Web of Science ®Google Scholar
• Datta S, Chatterjee S, Veer V, et al. Molecular biology of the hepatitis B virus for clinicians. J Clin Exp Hepatol. 2012;2(4):353–365.
   PubMedGoogle Scholar
• Sattler F, Robinson WS. Hepatitis B viral DNA molecules have cohesive ends. J Virol. 1979;32(1):226–233.
   PubMed Web of Science ®Google Scholar
• Ou J-H, Bao H, Shih C, et al. Preferred translation of human hepatitis B virus polymerase from core protein-but not from precore protein-specific transcript. J Virol. 1990;64(9):4578–4581.
   PubMed Web of Science ®Google Scholar
• Ou J-H, Laub O, Rutter WJ. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Nat Acad Sci. 1986;83(6):1578–1582.
   PubMed Web of Science ®Google Scholar
• Le Seyec J, Chouteau P, Cannie I, et al. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol. 1999;73(3):2052–2057.
   PubMed Web of Science ®Google Scholar
• Ou J, Rutter WJ. Hybrid hepatitis B virus-host transcripts in a human hepatoma cell. research support, U.S. Gov’t, P.H.S. Proc Natl Acad Sci U S A. 1985 Jan;82(1):83–87. DOI:10.1073/pnas.82.1.83.
   PubMed Web of Science ®Google Scholar
• Lucifora J, Arzberger S, Durantel D, et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol. 2011;55(5):996–1003. DOI:10.1016/j.jhep.2011.02.015.
   PubMed Web of Science ®Google Scholar
• Pontisso P, Ruvoletto MG, Gerlich WH, et al. Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology. 1989;173(2):522–530.
   PubMed Web of Science ®Google Scholar
• Neurath AR, Seto B, Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine. 1989;7(3):234–236.
   PubMed Web of Science ®Google Scholar
• Gripon P, Cannie I, Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol. 2005;79(3):1613–1622.
   PubMed Web of Science ®Google Scholar
• Neurath A, Kent S, Strick N, et al. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 1986;46(3):429–436.
   PubMed Web of Science ®Google Scholar
• Abou Jaoudé G, Sureau C. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J Virol. 2005;79(16):10460–10466.
   PubMed Web of Science ®Google Scholar
• Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans. Hepatology. 2007;46(6):1759–1768.
   PubMed Web of Science ®Google Scholar
• Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. elife. 2012;1:e00049.
   PubMed Web of Science ®Google Scholar
• Stieger B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol. 2011;201:205–259.
   PubMedGoogle Scholar
• Iwamoto M, Watashi K, Tsukuda S, et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem Biophys Res Commun. 2014;443(3):808–813. DOI:10.1016/j.bbrc.2013.12.052.
   PubMed Web of Science ®Google Scholar
• König A, Döring B, Mohr C, et al. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes. J Hepatol. 2014;61(4):867–875.
   PubMed Web of Science ®Google Scholar
• Ni Y, Lempp FA, Mehrle S, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology. 2014;146(4):1070–1083. e6.
   PubMed Web of Science ®Google Scholar
• Michailidis E, Pabon J, Xiang K, et al. A robust cell culture system supporting the complete life cycle of hepatitis B virus. Sci Rep. 2017;7(1):1–11.
   PubMedGoogle Scholar
• Qiao L, Sui J, Luo G. Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication. J Virol. 2018;92:23.
   Web of Science ®Google Scholar
• Li H, Zhuang Q, Wang Y, et al. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol Immunol. 2014;11(2):175–183.
   PubMed Web of Science ®Google Scholar
• He W, Cao Z, Mao F, et al. Modification of three amino acids in sodium taurocholate cotransporting polypeptide renders mice susceptible to infection with Hepatitis D Virus in vivo. J Virol. 2016 Oct 1;90(19):8866–8874. DOI:10.1128/JVI.00901-16.
   PubMed Web of Science ®Google Scholar
• Winer BY, Shirvani-Dastgerdi E, Bram Y, et al. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med. 2018 Jun 27;10(447). DOI:10.1126/scitranslmed.aap9328.
   PubMed Web of Science ®Google Scholar
• Yang PL, Althage A, Chung J, et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13825–13830. DOI:10.1073/pnas.202398599.
   PubMed Web of Science ®Google Scholar
• Chisari FV, Pinkert CA, Milich DR, et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science. 1985 Dec 6;230(4730):1157–1160. DOI:10.1126/science.3865369.
   PubMed Web of Science ®Google Scholar
• Lempp FA, Mutz P, Lipps C, et al. Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor. J Hepatol. 2016 Mar;64(3):556–564. DOI:10.1016/j.jhep.2015.10.030.
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Saso W, Sugiyama R, et al. Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization. Proc Nat Acad Sci. 2019;116(17):8487–8492.
   PubMed Web of Science ®Google Scholar
• Macovei A, Radulescu C, Lazar C, et al. Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. J Virol. 2010;84(1):243–253.
   PubMed Web of Science ®Google Scholar
• Gripon P, Rumin S, Urban S, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Nat Acad Sci. 2002;99(24):15655–15660.
   PubMed Web of Science ®Google Scholar
• Herrscher C, Pastor F, Burlaud-Gaillard J, et al. Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis. Cell Microbiol. 2020 Aug;22(8):e13205. DOI:10.1111/cmi.13205.
   PubMed Web of Science ®Google Scholar
• Umetsu T, Inoue J, Kogure T, et al. Inhibitory effect of silibinin on hepatitis B virus entry. Biochem Biophys Rep. 2018Jul;14:20–25. DOI:10.1016/j.bbrep.2018.03.003.
   PubMedGoogle Scholar
• Liu Q, Somiya M, Shimada N, et al. Mutational analysis of hepatitis B virus pre-S1 (9-24) fusogenic peptide. Biochem Biophys Res Commun. 2016 May 27;474(2):406–412. DOI:10.1016/j.bbrc.2016.04.125.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Crespo I, Nunez E, Yelamos B, et al. Fusogenic activity of hepadnavirus peptides corresponding to sequences downstream of the putative cleavage site. Virology. 1999 Aug 15;261(1):133–142. DOI:10.1006/viro.1999.9823.
   PubMed Web of Science ®Google Scholar
• Funk A, Mhamdi M, Lin L, et al. Itinerary of hepatitis B viruses: delineation of restriction points critical for infectious entry. J Virol. 2004;78(15):8289–8300.
   PubMed Web of Science ®Google Scholar
• Rabe B, Glebe D, Kann M. Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events. J Virol. 2006;80(11):5465–5473.
   PubMed Web of Science ®Google Scholar
• Panté N, Kann M. Nuclear pore complex is able to transport macromolecules with diameters of∼ 39 nm. Mol Biol Cell. 2002;13(2):425–434.
   PubMed Web of Science ®Google Scholar
• Kann M, Sodeik B, Vlachou A, et al. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J Cell Biol. 1999;145(1):45–55.
   PubMed Web of Science ®Google Scholar
• Rabe B, Vlachou A, Panté N, et al. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Nat Acad Sci. 2003;100(17):9849–9854.
   PubMed Web of Science ®Google Scholar
• Schmitz A, Schwarz A, Foss M, et al. Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket. PLoS Pathog. 2010;6(1):e1000741.
   PubMed Web of Science ®Google Scholar
• Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 1986;47(3):451–460.
   PubMed Web of Science ®Google Scholar
• Dezhbord M, Lee S, Kim W, et al. Characterization of the molecular events of covalently closed circular DNA synthesis in de novo Hepatitis B virus infection of human hepatoma cells. Antiviral Res. 2019Mar;163:11–18. DOI:10.1016/j.antiviral.2019.01.004.
   PubMed Web of Science ®Google Scholar
• Hu J, Tang L, Cheng J, et al. Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases. Emerg Microbes Infect. 2021 Dec;10(1):852–864. DOI:10.1080/22221751.2021.1919034.
   PubMed Web of Science ®Google Scholar
• Fourel I, Saputelli J, Schaffer P, et al. The carbocyclic analog of 2’-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. J Virol. 1994 Feb;68(2):1059–1065. DOI:10.1128/JVI.68.2.1059-1065.1994.
   PubMed Web of Science ®Google Scholar
• Königer C, Wingert I, Marsmann M, et al. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proc Natl Acad Sci U S A. 2014 Oct;111(40):E4244–53. DOI:10.1073/pnas.1409986111.
   PubMed Web of Science ®Google Scholar
• Qi Y, Gao Z, Xu G, et al. DNA Polymerase κ is a key cellular factor for the formation of covalently closed circular DNA of Hepatitis B Virus. PLoS Pathog. 2016 Oct;12(10):e1005893. DOI:10.1371/journal.ppat.1005893.
   PubMed Web of Science ®Google Scholar
• Tang L, Sheraz M, McGrane M, et al. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA. PLoS Pathog. 2019;15(4):e1007742.
   PubMed Web of Science ®Google Scholar
• Long Q, Yan R, Hu J, et al. The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation. PLoS Pathog. 2017;13(12):e1006784. 12. DOI:10.1371/journal.ppat.1006784.
   PubMed Web of Science ®Google Scholar
• Sheraz M, Cheng J, Tang L, et al. Cellular DNA topoisomerases are required for the synthesis of Hepatitis B Virus covalently closed circular DNA. J Virol. 2019;93(11): 06. DOI:10.1128/JVI.02230-18.
   PubMed Web of Science ®Google Scholar
• Wei L, Ploss A. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation. Nat Microbiol. 2020;5(5):715–726. 05. DOI:10.1038/s41564-020-0678-0.
   PubMed Web of Science ®Google Scholar
• Wei L, Ploss A. Hepatitis B virus cccDNA is formed through distinct repair processes of each strand. Nat Commun. 2021;12(1):1591. 03. DOI:10.1038/s41467-021-21850-9.
   PubMed Web of Science ®Google Scholar
• Luo J, Luckenbaugh L, Hu H, et al. Involvement of host atr-chk1 pathway in Hepatitis B Virus covalently closed circular DNA formation. mBio. 2020;11(1): 02. DOI:10.1128/mBio.03423-19.
   Web of Science ®Google Scholar
• Diogo Dias J, Sarica N, Neuveut C. Early steps of Hepatitis b life cycle: from capsid nuclear import to cccDNA formation. Viruses. 2021;13(5). DOI:10.3390/v13050757.
   PubMed Web of Science ®Google Scholar
• Bock C-T, Schranz P, Schröder CH, et al. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes. 1994;8(2):215–229.
   PubMedGoogle Scholar
• Newbold JE, Xin H, Tencza M, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol. 1995;69(6):3350–3357.
   PubMed Web of Science ®Google Scholar
• Bock CT, Schwinn S, Locarnini S, et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol. 2001;307(1):183–196.
   PubMed Web of Science ®Google Scholar
• Belloni L, Pollicino T, De Nicola F, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A. 2009 Nov;106(47):19975–19979. DOI:10.1073/pnas.0908365106.
   PubMed Web of Science ®Google Scholar
• Pollicino T, Belloni L, Raffa G, et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology. 2006 Mar;130(3):823–837. DOI:10.1053/j.gastro.2006.01.001.
   PubMed Web of Science ®Google Scholar
• Benhenda S, Ducroux A, Rivière L, et al. Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription. J Virol. 2013 Apr;87(8):4360–4371. DOI:10.1128/JVI.02574-12.
   PubMed Web of Science ®Google Scholar
• Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem. 1987;56(1):651–693.
   PubMedGoogle Scholar
• Huang Z-M YT. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol Cell Biol. 1995;15(7):3864–3869.
   PubMed Web of Science ®Google Scholar
• Yaginuma K, Koike K. Identification of a promoter region for 3.6-kilobase mRNA of hepatitis B virus and specific cellular binding protein. J Virol. 1989;63(7):2914–2920.
   PubMed Web of Science ®Google Scholar
• Yuh C, Chang Y, Ting L. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol. 1992;66(7):4073–4084.
   PubMed Web of Science ®Google Scholar
• Chen I-H, Huang C-J, Ting L-P. Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J Virol. 1995;69(6):3647–3657.
   PubMed Web of Science ®Google Scholar
• Gerlach KK, Schloemer RH. Hepatitis B virus C gene promoter is under negative regulation. Virology. 1992;189(1):59–66.
   PubMed Web of Science ®Google Scholar
• Chen M, J-H OU. Cell type-dependent regulation of the activity of the negative regulatory element of the hepatitis B virus core promoter. Virology. 1995;214(1):198–206.
   PubMed Web of Science ®Google Scholar
• Zhou DX, Yen TS. The hepatitis B virus S promoter comprises A CCAAT motif and two initiation regions. J Biol Chem. 1991 Dec 5;266(34):23416–23421.
   PubMed Web of Science ®Google Scholar
• Guo WT, Wang J, Tam G, et al. Leaky transcription termination produces larger and smaller than genome size hepatitis B virus X gene transcripts. Virology. 1991 Apr;181(2):630–636. DOI:10.1016/0042-6822(91)90896-j.
   PubMed Web of Science ®Google Scholar
• Doitsh G, Shaul Y. A long HBV transcript encoding pX is inefficiently exported from the nucleus. Virology. 2003 May 10;309(2):339–349. DOI:10.1016/s0042-6822(03)00156-9.
   PubMed Web of Science ®Google Scholar
• Guo WT, Bell KD, Ou JH. Characterization of the hepatitis B virus EnhI enhancer and X promoter complex. J Virol. 1991 Dec;65(12):6686–6692. DOI:10.1128/JVI.65.12.6686-6692.1991.
   PubMed Web of Science ®Google Scholar
• Yee JK. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science. 1989 Nov 3;246(4930):658–661. DOI:10.1126/science.2554495.
   PubMed Web of Science ®Google Scholar
• López-Cabrera M, Letovsky J, K-Q H, et al. Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology. 1991;183(2):825–829.
   PubMed Web of Science ®Google Scholar
• Antonucci TK, Rutter WJ. Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner. J Virol. 1989 Feb;63(2):579–583. DOI:10.1128/JVI.63.2.579-583.1989.
   PubMed Web of Science ®Google Scholar
• Trujillo MA, Letovsky J, Maguire HF, et al. Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc Nat Acad Sci. 1991;88(9):3797–3801.
   PubMed Web of Science ®Google Scholar
• Raney A, Easton A, Milich D, et al. Promoter-specific transactivation of hepatitis B virus transcription by a glutamine-and proline-rich domain of hepatocyte nuclear factor 1. J Virol. 1991;65(11):5774–5781.
   PubMed Web of Science ®Google Scholar
• Raney AK, Zhang P, McLachlan A. Regulation of transcription from the hepatitis B virus large surface antigen promoter by hepatocyte nuclear factor 3. J Virol. 1995;69(6):3265–3272.
   PubMed Web of Science ®Google Scholar
• Wang W, Li M, Wu X, et al. HNF1 is critical for the liver-specific function of HBV enhancer II. Res Virol. 1998;149(2):99–108.
   PubMedGoogle Scholar
• LI M, XIE Y, WU X, et al. HNF3 binds and activates the second enhancer, ENII, of hepatitis B virus. Virology. 1995;214(2):371–378.
   PubMed Web of Science ®Google Scholar
• Slagle BL, Bouchard MJ. Hepatitis B virus X and regulation of viral gene expression. Cold Spring Harb Perspect Med. 2016;6(3):a021402.
   PubMed Web of Science ®Google Scholar
• Chen M, Hieng S, Qian X, et al. Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3. Virology. 1994 Nov;205(1):127–132. DOI:10.1006/viro.1994.1627.
   PubMed Web of Science ®Google Scholar
• Waris G, Siddiqui A. Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function. J Virol. 2002;76(6):2721–2729.
   PubMed Web of Science ®Google Scholar
• Bock CT, Kubicka S, Manns MP, et al. Two control elements in the hepatitis B virus S‐promoter are important for full promoter activity mediated by CCAAT‐binding factor. Hepatology. 1999;29(4):1236–1247.
   PubMed Web of Science ®Google Scholar
• Lu CC, Chen M, Ou JH, et al. Key role of a CCAAT element in regulating hepatitis B virus surface protein expression. Virology. 1995 Feb;206(2):1155–1158. DOI:10.1006/viro.1995.1042.
   PubMed Web of Science ®Google Scholar
• Lopez-Cabrera M, Letovsky J, K-Q H, et al. Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein. Proc Nat Acad Sci. 1990;87(13):5069–5073.
   PubMed Web of Science ®Google Scholar
• Zhou J, Tan T, Tian Y, et al. Kruppel-like factor 15 activates hepatitis B virus gene expression and replication. Hepatology. 2011 Jul;54(1):109–121. DOI:10.1002/hep.24362.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Li J, J-h O. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J Virol. 2004;78(13):6908–6914.
   PubMed Web of Science ®Google Scholar
• Guo W, Chen M, Yen T, et al. Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol Cell Biol. 1993;13(1):443–448.
   PubMed Web of Science ®Google Scholar
• Lin WJ, Li J, Lee YF, et al. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4. J Biol Chem. 2003 Mar;278(11):9353–9360. DOI:10.1074/jbc.M205944200.
   PubMed Web of Science ®Google Scholar
• Raney A, Milich D, Easton A, et al. Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol. 1990;64(5):2360–2368.
   PubMed Web of Science ®Google Scholar
• Li J, Ou JH. Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor. J Virol. 2001 Sep;75(18):8400–8406. DOI:10.1128/jvi.75.18.8400-8406.2001.
   PubMed Web of Science ®Google Scholar
• Huan B, Kosovsky MJ, Siddiqui A. Retinoid X receptor alpha transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor. J Virol. 1995;69(1):547–551.
   PubMed Web of Science ®Google Scholar
• Tang H, Raney AK, McLachlan A. Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture. J Virol. 2001;75(19):8937–8948.
   PubMed Web of Science ®Google Scholar
• Raney AK, Johnson JL, Palmer C, et al. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J Virol. 1997;71(2):1058–1071.
   PubMed Web of Science ®Google Scholar
• Ramière C, Scholtès C, Diaz O, et al. Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRα. J Virol. 2008;82(21):10832–10840. DOI:10.1128/JVI.00883-08.
   PubMed Web of Science ®Google Scholar
• Garcia AD, Ostapchuk P, Hearing P. Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I. J Virol. 1993;67(7):3940–3950.
   PubMed Web of Science ®Google Scholar
• Tian Y, Kuo CF, Chen WL, et al. Enhancement of hepatitis B virus replication by androgen and its receptor in mice. J Virol. 2012 Feb;86(4):1904–1910. DOI:10.1128/JVI.06707-11.
   PubMed Web of Science ®Google Scholar
• Wang SH, Yeh SH, Lin WH, et al. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology. 2009 Nov;50(5):1392–1402. DOI:10.1002/hep.23163.
   PubMed Web of Science ®Google Scholar
• Ko HL, Ren EC. Novel poly (ADP-ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repair. Hepatology. 2011 Oct;54(4):1190–1198. DOI:10.1002/hep.24502.
   PubMed Web of Science ®Google Scholar
• Buckwold VE, Chen M, Ou JH. Interaction of transcription factors RFX1 and MIBP1 with the gamma motif of the negative regulatory element of the hepatitis B virus core promoter. Virology. 1997 Jan;227(2):515–518. DOI:10.1006/viro.1996.8360.
   PubMed Web of Science ®Google Scholar
• Kramvis A, Kew M. The core promoter of hepatitis B virus. J Viral Hepat. 1999;6(6):415–427.
   PubMed Web of Science ®Google Scholar
• Moolla N, Kew M, Arbuthnot P. Regulatory elements of hepatitis B virus transcription. J Viral Hepat. 2002;9(5):323–331.
   PubMed Web of Science ®Google Scholar
• Quasdorff M, Protzer U. Control of hepatitis B virus at the level of transcription. J Viral Hepat. 2010;17(8):527–536.
   PubMed Web of Science ®Google Scholar
• Kim DH, Kang HS, Kim K-H. Roles of hepatocyte nuclear factors in hepatitis B virus infection. World J Gastroenterol. 2016;22(31):7017.
   PubMed Web of Science ®Google Scholar
• Turton KL, Meier-Stephenson V, Badmalia MD, et al. Host transcription factors in hepatitis B virus RNA synthesis. Viruses. 2020;12(2):160.
   PubMed Web of Science ®Google Scholar
• Wu HL, Chen PJ, Lin MH, et al. Temporal aspects of major viral transcript expression in Hep G2 cells transfected with cloned hepatitis B virus DNA: with emphasis on the X transcript. Virology. 1991 Dec;185(2):644–651. DOI:10.1016/0042-6822(91)90535-j.
   PubMed Web of Science ®Google Scholar
• Doitsh G, Shaul Y. Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol. 2004 Feb;24(4):1799–1808. DOI:10.1128/MCB.24.4.1799-1808.2004.
   PubMed Web of Science ®Google Scholar
• Xu Z, Yen TS, Wu L, et al. Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol. 2002 Mar;76(5):2579–2584. DOI:10.1128/jvi.76.5.2579-2584.2002.
   PubMed Web of Science ®Google Scholar
• Yu X, Mertz JE. Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J Virol. 1997;71(12):9366–9374.
   PubMed Web of Science ®Google Scholar
• Imam H, Khan M, Gokhale NS, et al. N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle. Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):8829–8834. DOI:10.1073/pnas.1808319115.
   PubMed Web of Science ®Google Scholar
• Kim GW, Imam H, Siddiqui A. The RNA binding proteins YTHDC1 and FMRP regulate the nuclear export of N(6)-methyladenosine-modified Hepatitis B Virus transcripts and affect the viral life cycle. J Virol. 2021 Jun 10;95(13):e0009721. DOI:10.1128/JVI.00097-21.
   PubMed Web of Science ®Google Scholar
• Mao R, Nie H, Cai D, et al. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog. 2013;9(7):e1003494.
   PubMed Web of Science ®Google Scholar
• Aly HH, Suzuki J, Watashi K, et al. RNA Exosome Complex Regulates Stability of the Hepatitis B Virus X-mRNA Transcript in a Non-stop-mediated (NSD) RNA Quality Control Mechanism. J Biol Chem. 2016;291(31):15958–15974. 07. DOI:10.1074/jbc.M116.724641.
   PubMed Web of Science ®Google Scholar
• Leong CR, Funami K, Oshiumi H, et al. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo. Oncotarget. 2016;7(42):68179–68193. 10. DOI:10.18632/oncotarget.11907.
   PubMedGoogle Scholar
• Liu Y, Nie H, Mao R, et al. Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA. PLoS Pathog. 2017 Apr;13(4):e1006296. DOI:10.1371/journal.ppat.1006296.
   PubMed Web of Science ®Google Scholar
• Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral Res. 2020;182:104925. DOI:10.1016/j.antiviral.2020.104925. 10.
   PubMed Web of Science ®Google Scholar
• Lin C-G, Lo SJ. Evidence for involvement of a ribosomal leaky scanning mechanism in the translation of the hepatitis B virus pol gene from the viral pregenome RNA. Virology. 1992;188(1):342–352.
   PubMed Web of Science ®Google Scholar
• Fouillot N, Tlouzeau S, Rossignol J, et al. Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation. J Virol. 1993;67(8):4886–4895.
   PubMed Web of Science ®Google Scholar
• Sen N, Cao F, Tavis JE. Translation of duck hepatitis B virus reverse transcriptase by ribosomal shunting. J Virol. 2004;78(21):11751–11757.
   PubMed Web of Science ®Google Scholar
• Cao F, Tavis JE. RNA elements directing translation of the duck hepatitis B Virus polymerase via ribosomal shunting. J Virol. 2011;85(13):6343–6352.
   PubMed Web of Science ®Google Scholar
• Conway JF, Cheng N, Zlotnick A, et al. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature. 1997;386(6620):91–94.
   PubMed Web of Science ®Google Scholar
• Liao W, Ou JH. Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs. J Virol. 1995 Feb;69(2):1025–1029. DOI:10.1128/JVI.69.2.1025-1029.1995.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Hu Z, Cheng J, et al. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation. J Virol. 2018;92(13). 07. DOI:10.1128/JVI.02139-17.
   Web of Science ®Google Scholar
• Gazina EV, Fielding JE, Lin B, et al. Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. J Virol. 2000;74(10):4721–4728.
   PubMed Web of Science ®Google Scholar
• Lan YT, Li J, Liao W, et al. Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication. Virology. 1999 Jul 5;259(2):342–348. DOI:10.1006/viro.1999.9798.
   PubMed Web of Science ®Google Scholar
• Ludgate L, Ning X, Nguyen DH, et al. Cyclin-dependent kinase 2 phosphorylates s/tp sites in the hepadnavirus core protein C-terminal domain and is incorporated into viral capsids. J Virol. 2012;86(22):12237–12250.
   PubMed Web of Science ®Google Scholar
• Liu H, Xi J, Hu J. Regulation of Hepatitis B Virus Replication by Cyclin Docking Motifs in Core Protein. J Virol. 2021;95(12). DOI:10.1128/JVI.00230-21.
   Web of Science ®Google Scholar
• Diab A, Foca A, Fusil F, et al. Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication. Hepatology. 2017;66(6):1750–1765. DOI:10.1002/hep.29236.
   PubMed Web of Science ®Google Scholar
• Kang HY, Lee S, Park SG, et al. Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochem J. 2006;398(2):311–317.
   PubMedGoogle Scholar
• Kann M, Gerlich WH. Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol. 1994;68(12):7993–8000.
   PubMed Web of Science ®Google Scholar
• Daub H, Blencke S, Habenberger P, et al. Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. J Virol. 2002;76(16):8124–8137. DOI:10.1128/JVI.76.16.8124-8137.2002.
   PubMed Web of Science ®Google Scholar
• Heger-Stevic J, Zimmermann P, Lecoq L, et al. Hepatitis B virus core protein phosphorylation: identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure. PLoS Pathog. 2018;14(12):e1007488.
   PubMed Web of Science ®Google Scholar
• Hu Z, Ban H, Zheng H, et al. Protein phosphatase 1 catalyzes HBV core protein dephosphorylation and is co-packaged with viral pregenomic RNA into nucleocapsids. PLoS Pathog. 2020 Jul;16(7):e1008669. DOI:10.1371/journal.ppat.1008669.
   PubMed Web of Science ®Google Scholar
• Xi J, Luckenbaugh L, Hu J. Multiple roles of PP2A binding motif in hepatitis B virus core linker and PP2A in regulating core phosphorylation state and viral replication. PLoS Pathog. 2021 Jan;17(1):e1009230. DOI:10.1371/journal.ppat.1009230.
   PubMed Web of Science ®Google Scholar
• Yeh CT, Liaw YF, Ou JH. The arginine-rich domain of hepatitis B virus precore and core proteins contains a signal for nuclear transport. J Virol. 1990 Dec;64(12):6141–6147. DOI:10.1128/JVI.64.12.6141-6147.1990.
   PubMed Web of Science ®Google Scholar
• Li HC, Huang EY, Su PY, et al. Nuclear export and import of human hepatitis B virus capsid protein and particles. PLoS Pathog. 2010 Oct 28;6(10):e1001162. DOI:10.1371/journal.ppat.1001162.
   PubMed Web of Science ®Google Scholar
• Wang J, Lee AS, Ou JH. Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment. J Virol. 1991 Sep;65(9):5080–5083. DOI:10.1128/JVI.65.9.5080-5083.1991.
   PubMed Web of Science ®Google Scholar
• Yeh CT, Hong LH, Ou JH, et al. Characterization of nuclear localization of a hepatitis B virus precore protein derivative P22. Arch Virol. 1996;141(3–4):425–438.
   PubMed Web of Science ®Google Scholar
• Yeh CT, Ou JH. Phosphorylation of hepatitis B virus precore and core proteins. J Virol. 1991 May;65(5):2327–2331. DOI:10.1128/JVI.65.5.2327-2331.1991.
   PubMed Web of Science ®Google Scholar
• Schodel F, Peterson D, Zheng J, et al. Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J Biol Chem. 1993 Jan 15;268(2):1332–1337.
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Matzke B, Pasquinelli C, et al. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J Virol. 1996 Oct;70(10):7056–7061. DOI:10.1128/JVI.70.10.7056-7061.1996.
   PubMed Web of Science ®Google Scholar
• Mitra B, Wang J, Kim ES, et al. Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation. J Virol. 2019 Jul 1;93(13). DOI:10.1128/JVI.00196-19.
   Web of Science ®Google Scholar
• Brunetto M, Giarin M, Oliveri F, et al. ‘e’Antigen defective hepatitis B virus and course of chronic infection. J Hepatol. 1991;13:S82–S86.
   PubMed Web of Science ®Google Scholar
• Milich DR, Jones JE, Hughes JL, et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Nat Acad Sci. 1990;87(17):6599–6603.
   PubMed Web of Science ®Google Scholar
• Visvanathan K, Skinner NA, Thompson AJ, et al. Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein. Hepatology. 2007;45(1):102–110. DOI:10.1002/hep.21482.
   PubMed Web of Science ®Google Scholar
• Lang T, Lo C, Skinner N, et al. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol. 2011;55(4):762–769.
   PubMed Web of Science ®Google Scholar
• Tian Y, Kuo CF, Akbari O, et al. Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission. Immunity. 2016 May 17;44(5):1204–1214. DOI:10.1016/j.immuni.2016.04.008.
   PubMed Web of Science ®Google Scholar
• Chen M, Sällberg M, Hughes J, et al. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol. 2005;79(5):3016–3027. DOI:10.1128/JVI.79.5.3016-3027.2005.
   PubMed Web of Science ®Google Scholar
• Stirk H, Thornton J, Howard C. Atopological Model for Hepatitis B Surface Antigen. Intervirology. 1992;33(3):148–158.
   PubMed Web of Science ®Google Scholar
• Eble B, MacRae D, Lingappa V, et al. Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol. 1987;7(10):3591–3601.
   PubMed Web of Science ®Google Scholar
• Dobrica M-O, Lazar C, Branza-Nichita N. N-glycosylation and N-glycan processing in HBV biology and pathogenesis. Cells. 2020;9(6):1404.
   PubMed Web of Science ®Google Scholar
• Heermann K, Goldmann U, Schwartz W, et al. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol. 1984;52(2):396–402.
   PubMed Web of Science ®Google Scholar
• Gavilanes F, Gonzalez-Ros JM, Peterson DL. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J Biol Chem. 1982;257(13):7770–7777.
   PubMed Web of Science ®Google Scholar
• Prange R. Host factors involved in hepatitis B virus maturation, assembly, and egress. Med Microbiol Immunol. 2012;201(4):449–461.
   PubMed Web of Science ®Google Scholar
• Werr M, Prange R. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles. J Virol. 1998;72(1):778–782.
   PubMed Web of Science ®Google Scholar
• Mehta A, Lu X, Block TM, et al. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc Nat Acad Sci. 1997;94(5):1822–1827.
   PubMed Web of Science ®Google Scholar
• LU X, Mehta A, Dwek R, et al. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion. Virology. 1995;213(2):660–665.
   PubMed Web of Science ®Google Scholar
• Schmitt S, Glebe D, Alving K, et al. Analysis of the pre-S2 N-and O-linked glycans of the M surface protein from human hepatitis B virus. J Biol Chem. 1999;274(17):11945–11957. DOI:10.1074/jbc.274.17.11945.
   PubMed Web of Science ®Google Scholar
• Schmitt S, Glebe D, Tolle TK, et al. Structure of pre-S2 N-and O-linked glycans in surface proteins from different genotypes of hepatitis B virus. J Gen Virol. 2004;85(7):2045–2053. DOI:10.1099/vir.0.79932-0.
   PubMedGoogle Scholar
• Fernholz D, Stemler M, Brunetto M, et al. Replicating and virion secreting hepatitis B mutant virus unable to produce preS2 protein. J Hepatol. 1991;13:S102–S104.
   PubMed Web of Science ®Google Scholar
• Ni Y, Sonnabend J, Seitz S, et al. The pre-s2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly. J Virol. 2010;84(8):3879–3888.
   PubMed Web of Science ®Google Scholar
• Luan F, Liu H, Gao L, et al. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Gut. 2009;58(11):1528–1537. DOI:10.1136/gut.2008.174029.
   PubMed Web of Science ®Google Scholar
• Luan F, Liu B, Zhang J, et al. Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma. Pathol Res Pract. 2017;213(9):1037–1042.
   PubMed Web of Science ®Google Scholar
• Zhang X, Gao L, Liang X, et al. HBV preS2 transactivates FOXP 3 expression in malignant hepatocytes. Liver Int. 2015;35(3):1087–1094. DOI:10.1111/liv.12642.
   PubMed Web of Science ®Google Scholar
• Brancaccio G, Salpini R, Piermatteo L, et al. An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms. 2021;9(4):752. DOI:10.3390/microorganisms9040752.
   PubMed Web of Science ®Google Scholar
• Bruss V, Vieluf K. Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J Virol. 1995;69(11):6652–6657.
   PubMed Web of Science ®Google Scholar
• Prange R, Streeck RE. Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J. 1995;14(2):247–256.
   PubMed Web of Science ®Google Scholar
• Bruss V. A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation. J Virol. 1997;71(12):9350.
   PubMed Web of Science ®Google Scholar
• Poisson F, Severac A, Hourioux C, et al. Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle. Virology. 1997;228(1):115–120.
   PubMed Web of Science ®Google Scholar
• Löffler-Mary H, Dumortier J, Klentsch-Zimmer C, et al. Hepatitis B virus assembly is sensitive to changes in the cytosolic S loop of the envelope proteins. Virology. 2000;270(2):358–367.
   PubMed Web of Science ®Google Scholar
• Bruss V, Lu X, Thomssen R, et al. Post‐translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J. 1994;13(10):2273–2279.
   PubMed Web of Science ®Google Scholar
• Ostapchuk P, Hearing P, Ganem D. A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J. 1994;13(5):1048–1057.
   PubMed Web of Science ®Google Scholar
• Lambert C, Prange R. Chaperone action in the posttranslational topological reorientation of the hepatitis B virus large envelope protein: implications for translocational regulation. Proc Nat Acad Sci. 2003;100(9):5199–5204.
   PubMed Web of Science ®Google Scholar
• Cho D-Y, Yang G-H, Ryu CJ, et al. Molecular chaperone GRP78/BiP interacts with the large surface protein of hepatitis B virus in vitro and in vivo. J Virol. 2003;77(4):2784–2788.
   PubMed Web of Science ®Google Scholar
• Awe K, Lambert C, Prange R. Mammalian BiP controls posttranslational ER translocation of the hepatitis B virus large envelope protein. FEBS Lett. 2008;582(21–22):3179–3184.
   PubMed Web of Science ®Google Scholar
• Löffler-Mary H, Werr M, Prange R. Sequence-specific repression of cotranslational translocation of the hepatitis B virus envelope proteins coincides with binding of heat shock protein Hsc70. Virology. 1997;235(1):144–152.
   PubMed Web of Science ®Google Scholar
• Bruss V, Hagelstein J, Gerhardt E, et al. Myristylation of the Large Surface Protein Is Required for Hepatitis B Virusin VitroInfectivity. Virology. 1996;218(2):396–399.
   PubMed Web of Science ®Google Scholar
• Gripon P, Le Seyec J, Rumin S, et al. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology. 1995;213(2):292–299.
   PubMed Web of Science ®Google Scholar
• Mangold C, Streeck RE. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol. 1993;67(8):4588–4597.
   PubMed Web of Science ®Google Scholar
• Seeger C, Zoulim F, Mason WS. Hepadnavirus. In: Knipe DM, and Howley PM, editors. Fields virology. chap. Vols. 2185-2221, Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins; 2013. p. 68.
   Google Scholar
• Persing DH, Varmus HE, Ganem D. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science. 1986;234(4782):1388–1391.
   PubMed Web of Science ®Google Scholar
• Ou JH, Rutter WJ. Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Virol. 1987 Mar;61(3):782–786. DOI:10.1128/JVI.61.3.782-786.1987.
   PubMed Web of Science ®Google Scholar
• Kekule AS, Lauer U, Meyer M, et al. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature. 1990;343(6257):457–461.
   PubMed Web of Science ®Google Scholar
• Caselmann WH, Meyer M, Kekule AS, et al. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Nat Acad Sci. 1990;87(8):2970–2974.
   PubMed Web of Science ®Google Scholar
• Ono M, Morisawa K, Nie J, et al. Transactivation of transforming growth factor α gene by hepatitis B virus preS1. Cancer Res. 1998;58(9):1813–1816.
   PubMed Web of Science ®Google Scholar
• Meyer M, Caselmann W, Schlüter V, et al. Hepatitis B virus transactivator MHBst: activation of NF‐kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J. 1992;11(8):2991–3001.
   PubMed Web of Science ®Google Scholar
• Hildt E, Saher G, Bruss V, et al. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology. 1996;225(1):235–239.
   PubMed Web of Science ®Google Scholar
• Gerken G, Kremsdorf D, Capel F, et al. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology. 1991;183(2):555–565. DOI:10.1016/0042-6822(91)90984-J.
   PubMed Web of Science ®Google Scholar
• Xu Z, Yen T. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J Virol. 1996;70(1):133.
   PubMed Web of Science ®Google Scholar
• Wang H-C, Wu H-C, Chen C-F, et al. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol. 2003;163(6):2441–2449.
   PubMed Web of Science ®Google Scholar
• Wang HC, Huang W, Lai MD, et al. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Research Support, Non-U.S. Gov’t Review. Cancer Sci. 2006 Aug;97(8):683–688. DOI:10.1111/j.1349-7006.2006.00235.x.
   PubMed Web of Science ®Google Scholar
• Bartenschlager R, Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 1992;11(9):3413–3420.
   PubMed Web of Science ®Google Scholar
• Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol. 1994;68(1):6.
   PubMed Web of Science ®Google Scholar
• Twu J, Schloemer RH. Transcriptional trans-activating function of hepatitis B virus. J Virol. 1987;61(11):3448.
   PubMed Web of Science ®Google Scholar
• Tang H, Delgermaa L, Huang F, et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol. 2005;79(9):5548. DOI:10.1128/JVI.79.9.5548-5556.2005.
   PubMed Web of Science ®Google Scholar
• Keasler VV, Hodgson AJ, Madden CR, et al. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol. 2007;81(6):2656.
   PubMed Web of Science ®Google Scholar
• Doria M, Klein N, Lucito R, et al. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J. 1995;14(19):4747–4757.
   PubMed Web of Science ®Google Scholar
• Seto E, Mitchell PJ, Yen TS. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature. 1990 Mar;344(6261):72–74. DOI:10.1038/344072a0.
   PubMed Web of Science ®Google Scholar
• Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science. 1991 May;252(5007):842–844. DOI:10.1126/science.1827531.
   PubMed Web of Science ®Google Scholar
• Barnabas S, Hai T, Andrisani OM. The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors. J Biol Chem. 1997 Aug 15;272(33):20684–20690. DOI:10.1074/jbc.272.33.20684.
   PubMed Web of Science ®Google Scholar
• Rahmani Z, Huh K-W, Lasher R, et al. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol. 2000;74(6):2840.
   PubMed Web of Science ®Google Scholar
• Takada S, Shirakata Y, Kaneniwa N, et al. Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene. 1999;18(50):6965–6973.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Khan M, Quan J, et al. Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathog. 2013;9(12):e1003722.
   PubMed Web of Science ®Google Scholar
• Murakami S, Cheong J, Kaneko S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem. 1994;269(21):15118–15123.
   PubMed Web of Science ®Google Scholar
• Kumar V, Jayasuryan N, Kumar R. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Nat Acad Sci. 1996;93(11):5647–5652.
   PubMed Web of Science ®Google Scholar
• Reddi H, Kumar R, Jain SK, et al. A carboxy-terminal region of the hepatitis B virus X protein promotes DNA interaction of CREB and mimics the native protein for transactivation function. Virus Genes. 2003;26(3):227–238.
   PubMed Web of Science ®Google Scholar
• Nijhara R, Jana SS, Goswami SK, et al. An internal segment (residues 58–119) of the hepatitis B virus X protein is sufficient to activate MAP kinase pathways in mouse liver. FEBS Lett. 2001;504(1–2):59–64.
   PubMed Web of Science ®Google Scholar
• K-W H, Siddiqui A. Characterization of the mitochondrial association of hepatitis B virus X protein, HBx. Mitochondrion. 2002;1(4):349–359.
   PubMed Web of Science ®Google Scholar
• Lizzano RA, Yang B, Clippinger AJ, et al. The C-terminal region of the hepatitis B virus X protein is essential for its stability and function. Virus Res. 2011;155(1):231–239.
   PubMed Web of Science ®Google Scholar
• Jiang T, Liu M, Wu J, et al. Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBx. Proc Nat Acad Sci. 2016;113(8):2074–2079.
   PubMed Web of Science ®Google Scholar
• Zhang T-Y, Chen H-Y, Cao J-L, et al. Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interaction. Nat Commun. 2019;10(1):1–14. DOI:10.1038/s41467-018-07882-8.
   PubMed Web of Science ®Google Scholar
• Lin M-H, Lo SJ. Dimerization of hepatitis B viral X protein synthesized in a cell-free system. Biochem Biophys Res Commun. 1989;164(1):14–21.
   PubMed Web of Science ®Google Scholar
• Melegari M, Scaglioni PP, Wands JR. Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol. 1998;72(3):1737–1743.
   PubMed Web of Science ®Google Scholar
• Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science. 2001 Dec;294(5550):2376–2378. DOI:10.1126/science.294.5550.2376.
   PubMed Web of Science ®Google Scholar
• Reifenberg K, Nusser P, Löhler J, et al. Virus replication and virion export in X-deficient hepatitis B virus transgenic mice. J Gen Virol. 2002;83(5):991–996. DOI:10.1099/0022-1317-83-5-991.
   PubMedGoogle Scholar
• Tsuge M, Hiraga N, Akiyama R, et al. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. J Gen Virol. 2010;91(7):1854–1864. DOI:10.1099/vir.0.019224-0.
   PubMedGoogle Scholar
• Leupin O, Bontron S, Schaeffer C, et al. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol. 2005;79(7):4238–4245.
   PubMed Web of Science ®Google Scholar
• Hodgson AJ, Hyser JM, Keasler VV, et al. Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology. 2012;426(1):73–82.
   PubMed Web of Science ®Google Scholar
• Kim W, Lee S, Son Y, et al. DDB1 stimulates viral transcription of hepatitis B virus via HBx-independent mechanisms. J Virol. 2016;90(21):9644–9653.
   PubMed Web of Science ®Google Scholar
• Yuan H, Zhao L, Yuan Y, et al. HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver. Theranostics. 2021;11(17):8362. DOI:10.7150/thno.57531.
   PubMed Web of Science ®Google Scholar
• G-w K, Siddiqui A. Hepatitis B virus X protein recruits methyltransferases to affect cotranscriptional N6-methyladenosine modification of viral/host RNAs. Proc Nat Acad Sci. 2021;118:3.
   Web of Science ®Google Scholar
• Zhou DX, Taraboulos A, Ou JH, et al. Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J Virol. 1990 Aug;64(8):4025–4028. DOI:10.1128/JVI.64.8.4025-4028.1990.
   PubMed Web of Science ®Google Scholar
• Amaro MJ, Bartolomé J, Carreño V. Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter. Hepatology. 1999 Mar;29(3):915–923. DOI:10.1002/hep.510290337.
   PubMed Web of Science ®Google Scholar
• Majano P. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation. Hepatology. 2001 Dec;34(6):1218–1224. DOI:10.1053/jhep.2001.29626.
   PubMed Web of Science ®Google Scholar
• Mahé Y, Mukaida N, Kuno K, et al. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem. 1991 Jul;266(21):13759–13763. DOI:10.1016/S0021-9258(18)92765-1.
   PubMed Web of Science ®Google Scholar
• Rossner MT. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol. 1992 Feb;36(2):101–117. DOI:10.1002/jmv.1890360207.
   PubMed Web of Science ®Google Scholar
• Unger T, Shaul Y. The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J. 1990 Jun;9(6):1889–1895.
   PubMed Web of Science ®Google Scholar
• Choi BH, Choi M, Jeon HY, et al. Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter. DNA Cell Biol. 2001 Feb;20(2):75–80. DOI:10.1089/104454901750070274.
   PubMed Web of Science ®Google Scholar
• Lara‐Pezzi E, Armesilla AL, Majano PL, et al. The hepatitis B virus X protein activates nuclear factor of activated T cells (NF‐AT) by a cyclosporin A‐sensitive pathway. EMBO J. 1998;17(23):7066–7077.
   PubMed Web of Science ®Google Scholar
• Wang XW, Forrester K, Yeh H, et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A. 1994 Mar;91(6):2230–2234. DOI:10.1073/pnas.91.6.2230.
   PubMed Web of Science ®Google Scholar
• Truant R, Antunovic J, Greenblatt J, et al. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol. 1995 Mar;69(3):1851–1859. DOI:10.1128/JVI.69.3.1851-1859.1995.
   PubMed Web of Science ®Google Scholar
• Yoo Y, Na T, Seo H, et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene. 2008;27(24):3405–3413. DOI:10.1038/sj.onc.1211000.
   PubMed Web of Science ®Google Scholar
• Li J, Xu Z, Zheng Y, et al. Regulation of hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B virus X proteins. J Virol. 2002 Jun;76(12):5875–5881. DOI:10.1128/jvi.76.12.5875-5881.2002.
   PubMed Web of Science ®Google Scholar
• Lee DK, Park SH, Yi Y, et al. The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev. 2001 Feb;15(4):455–466. DOI:10.1101/gad.856201.
   PubMed Web of Science ®Google Scholar
• Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol. 2001 Nov;21(22):7721–7730. DOI:10.1128/MCB.21.22.7721-7730.2001.
   PubMed Web of Science ®Google Scholar
• Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology. 2007 May;132(5):1955–1967. DOI:10.1053/j.gastro.2007.03.039.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chen WL, Ma WL, et al. Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology. 2007 Jul;363(2):454–461. DOI:10.1016/j.virol.2007.01.040.
   PubMed Web of Science ®Google Scholar
• Yen TS. Hepadnaviral X Protein: Reviewof Recent Progress. J Biomed Sci. 1996 Jan;3(1):20–30. DOI:10.1007/BF02253575.
   PubMedGoogle Scholar
• Cheong JH, Yi M, Lin Y, et al. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J. 1995 Jan;14(1):143–150.
   PubMed Web of Science ®Google Scholar
• Qadri I, Maguire HF, Siddiqui A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci U S A. 1995 Feb;92(4):1003–1007. DOI:10.1073/pnas.92.4.1003.
   PubMed Web of Science ®Google Scholar
• Wang HD, Trivedi A, Johnson DL. Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol. 1998 Dec;18(12):7086–7094. DOI:10.1128/MCB.18.12.7086.
   PubMed Web of Science ®Google Scholar
• Lin Y, Nomura T, Cheong J, et al. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem. 1997 Mar;272(11):7132–7139. DOI:10.1074/jbc.272.11.7132.
   PubMed Web of Science ®Google Scholar
• Qadri I, Conaway JW, Conaway RC, et al. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci U S A. 1996 Oct;93(20):10578–10583. DOI:10.1073/pnas.93.20.10578.
   PubMed Web of Science ®Google Scholar
• Cougot D, Wu Y, Cairo S, et al. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem. 2007 Feb;282(7):4277–4287. DOI:10.1074/jbc.M606774200.
   PubMed Web of Science ®Google Scholar
• Zhou SJ, Deng YL, Liang HF, et al. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma. Cell Death Differ. 2017;24(9):1577–1587. 09. DOI:10.1038/cdd.2017.87.
   PubMed Web of Science ®Google Scholar
• Yen CJ, Yang ST, Chen RY, et al. Hepatitis B virus X protein (HBx) enhances centrosomal P4.1-associated protein (CPAP) expression to promote hepatocarcinogenesis. J Biomed Sci. 2019 Jun;26(1):44. DOI:10.1186/s12929-019-0534-9.
   PubMedGoogle Scholar
• Huang J, Kwong J, Sun EC, et al. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol. 1996 Aug;70(8):5582–5591. DOI:10.1128/JVI.70.8.5582-5591.1996.
   PubMed Web of Science ®Google Scholar
• Fischer M, Runkel L, Schaller H. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes. 1995;10(1):99–102.
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhang Z, Doo E, et al. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol. 1999;73(9):7231.
   PubMed Web of Science ®Google Scholar
• Schek N, Bartenschlager R, Kuhn C, et al. Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene. 1991;6(10):1735–1744.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Torii N, Furusaka A, et al. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem. 2000 May;275(20):15157–15165. DOI:10.1074/jbc.M910378199.
   PubMed Web of Science ®Google Scholar
• Arii M, Takada S, Koike K. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene. 1992 Mar;7(3):397–403.
   PubMed Web of Science ®Google Scholar
• Lee T-H, Elledge SJ, Butel JS. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol. 1995;69(2):1107.
   PubMed Web of Science ®Google Scholar
• Sitterlin D, Lee T-H, Prigent S, et al. Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J Virol. 1997;71(8):6194.
   PubMed Web of Science ®Google Scholar
• Lin-Marq N, Bontron S, Leupin O, et al. Hepatitis B virus X protein interferes with cell viability through interaction with the p127-kDa UV-damaged DNA-binding protein. Virology. 2001;287(2):266–274.
   PubMed Web of Science ®Google Scholar
• Becker SA, Lee T-H, Butel JS, et al. Hepatitis B virus X protein interferes with cellular DNA repair. J Virol. 1998;72(1):266.
   PubMed Web of Science ®Google Scholar
• Bontron S, Lin-Marq N, Strubin M. Hepatitis B virus X protein associated with UV-DDB1 induces cell death in the nucleus and is functionally antagonized by UV-DDB2. J Biol Chem. 2002;277(41):38847–38854.
   PubMed Web of Science ®Google Scholar
• Bergametti F, Bianchi J, Transy C. Interaction of hepatitis B virus X protein with damaged DNA-binding protein p127: structural analysis and identification of antagonists. J Biomed Sci. 2002;9(6):706–715.
   PubMed Web of Science ®Google Scholar
• Li T, Robert EI, Van Breugel PC, et al. A promiscuous α-helical motif anchors viral hijackers and substrate receptors to the CUL4–DDB1 ubiquitin ligase machinery. Nat Struct Mol Biol. 2010;17(1):105.
   PubMed Web of Science ®Google Scholar
• Decorsiere A, Mueller H, van Breugel PC, et al. Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. Nature. 2016 Mar 17;531(7594):386–389. DOI:10.1038/nature17170.
   PubMed Web of Science ®Google Scholar
• Murphy CM, Xu Y, Li F, et al. Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication. Cell Rep. 2016 Sep 13;16(11):2846–2854. DOI:10.1016/j.celrep.2016.08.026.
   PubMed Web of Science ®Google Scholar
• Jia L, Wang XW, Harris CC. Hepatitis B virus X protein inhibits nucleotide excision repair. Int J Cancer. 1999 Mar;80(6):875–879. DOI:10.1002/(sici)1097-0215(19990315)80:6<875::aid-ijc13>3.0.co;2-z.
   PubMed Web of Science ®Google Scholar
• Jaitovich-Groisman I, Benlimame N, Slagle BL, et al. Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue. J Biol Chem. 2001 Apr;276(17):14124–14132. DOI:10.1074/jbc.M010852200.
   PubMed Web of Science ®Google Scholar
• Benedetti F, Curreli S, Gallo RC, et al. Tampering of Viruses and Bacteria with Host DNA Repair: implications for Cellular Transformation. Cancers (Basel). 2021 Jan;13(2):241. DOI:10.3390/cancers13020241.
   PubMed Web of Science ®Google Scholar
• Minor MM, Slagle BL. Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system. Viruses. 2014;6(11):4683–4702.
   PubMed Web of Science ®Google Scholar
• Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A. 1994 Oct;91(22):10350–10354. DOI:10.1073/pnas.91.22.10350.
   PubMed Web of Science ®Google Scholar
• Natoli G, Avantaggiati ML, Chirillo P, et al. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene. 1994 Oct;9(10):2837–2843.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Li J, Johnson DL, et al. Regulation of hepatitis B virus replication by the ras-mitogen-activated protein kinase signaling pathway. J Virol. 2003 Jul;77(14):7707–7712. DOI:10.1128/jvi.77.14.7707-7712.2003.
   PubMed Web of Science ®Google Scholar
• Benn J, Su F, Doria M, et al. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol. 1996 Aug;70(8):4978–4985. DOI:10.1128/JVI.70.8.4978-4985.1996.
   PubMed Web of Science ®Google Scholar
• Lee YH, Yun Y. HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem. 1998 Sep;273(39):25510–25515. DOI:10.1074/jbc.273.39.25510.
   PubMed Web of Science ®Google Scholar
• Lee YI, Kang-Park S, Do SI. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem. 2001 May;276(20):16969–16977. DOI:10.1074/jbc.M011263200.
   PubMed Web of Science ®Google Scholar
• Klein NP, Schneider RJ. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol. 1997 Nov;17(11):6427–6436. DOI:10.1128/MCB.17.11.6427.
   PubMed Web of Science ®Google Scholar
• Yang B, Bouchard MJ. The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake. J Virol. 2012 Jan;86(1):313–327. DOI:10.1128/JVI.06442-11.
   PubMed Web of Science ®Google Scholar
• Elmore LW, Hancock AR, Chang SF, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci U S A. 1997 Dec;94(26):14707–14712. DOI:10.1073/pnas.94.26.14707.
   PubMed Web of Science ®Google Scholar
• Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J Virol. 2004 Dec;78(23):12725–12734. DOI:10.1128/JVI.78.23.12725-12734.2004.
   PubMed Web of Science ®Google Scholar
• Sir D, Ann DK, Ou JH. Autophagy by hepatitis B virus and for hepatitis B virus. Autophagy. 2010 May;6(4):548–549. DOI:10.4161/auto.6.4.11669.
   PubMed Web of Science ®Google Scholar
• Nassal M, Junker-Niepmann M, Schaller H. Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell. 1990 Dec;63(6):1357–1363. DOI:10.1016/0092-8674(90)90431-d.
   PubMed Web of Science ®Google Scholar
• Basagoudanavar SH, Perlman DH, Hu J. Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation. J Virol. 2007 Feb;81(4):1641–1649. DOI:10.1128/JVI.01671-06.
   PubMed Web of Science ®Google Scholar
• Chua PK, Tang FM, Huang JY, et al. Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach. J Virol. 2010 Mar;84(5):2340–2351. DOI:10.1128/JVI.01666-09.
   PubMed Web of Science ®Google Scholar
• Patel N, White SJ, Thompson RF, et al. HBV RNA pre-genome encodes specific motifs that mediate interactions with the viral core protein that promote nucleocapsid assembly. Nat Microbiol. 2017 Jun;2(8):17098. DOI:10.1038/nmicrobiol.2017.98.
   PubMed Web of Science ®Google Scholar
• Hu J, Seeger C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Nat Acad Sci. 1996;93(3):1060–1064.
   PubMed Web of Science ®Google Scholar
• Hu J. Hepadnavirus assembly and reverse transcription require a multi‐component chaperone complex which is incorporated into nucleocapsids. EMBO J. 1997;16(1):59–68.
   PubMed Web of Science ®Google Scholar
• Prange R, Werr M, Löffler-Mary H. Chaperones involved in hepatitis B virus morphogenesis. Biological Chemistry. 1999;380(3). DOI:10.1515/BC.1999.042
   PubMed Web of Science ®Google Scholar
• Stahl M, Beck J, Nassal M. Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to ɛ RNA binding. J Virol. 2007;81(24):13354.
   PubMed Web of Science ®Google Scholar
• Hu J, Flores D, Toft D, et al. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J Virol. 2004;78(23):13122.
   PubMed Web of Science ®Google Scholar
• Yao Y, Yang B, Chen Y, et al. RNA-Binding Motif Protein 24 (RBM24) is involved in pregenomic rna packaging by mediating interaction between Hepatitis B virus polymerase and the epsilon element. J Virol. 2019;93(6):6. 03. DOI:10.1128/JVI.02161-18.
   Web of Science ®Google Scholar
• Kim S, Wang H, Ryu WS. Incorporation of eukaryotic translation initiation factor eIF4E into viral nucleocapsids via interaction with hepatitis B virus polymerase. J Virol. 2010 Jan;84(1):52–58. DOI:10.1128/JVI.01232-09.
   PubMed Web of Science ®Google Scholar
• Jeong H, Cho MH, Park SG, et al. Interaction between nucleophosmin and HBV core protein increases HBV capsid assembly. FEBS Lett. 2014 Mar;588(6):851–858. DOI:10.1016/j.febslet.2014.01.020.
   PubMed Web of Science ®Google Scholar
• Clark DN, Jones SA, Hu J. In vitro assays for RNA binding and protein priming of Hepatitis B virus polymerase. Methods Mol Biol. 2017;1540:157–177.
   PubMedGoogle Scholar
• Abraham TM, Loeb DD. Base pairing between the 5’ half of epsilon and a cis-acting sequence, phi, makes a contribution to the synthesis of minus-strand DNA for human hepatitis B virus. J Virol. 2006 May;80(9):4380–4387. DOI:10.1128/JVI.80.9.4380-4387.2006.
   PubMed Web of Science ®Google Scholar
• Tian Y, Sir D, Kuo CF, et al. Autophagy required for hepatitis B virus replication in transgenic mice. J Virol. 2011 Dec;85(24):13453–13456. DOI:10.1128/JVI.06064-11.
   PubMed Web of Science ®Google Scholar
• Sir D, Tian Y, Chen WL, et al. The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication. Proc Natl Acad Sci U S A. 2010 Mar;107(9):4383–4388. DOI:10.1073/pnas.0911373107.
   PubMed Web of Science ®Google Scholar
• Liu N, Tian R, Loeb DD. Base pairing among three cis-acting sequences contributes to template switching during hepadnavirus reverse transcription. Proc Natl Acad Sci U S A. 2003 Feb;100(4):1984–1989. DOI:10.1073/pnas.0436218100.
   PubMed Web of Science ®Google Scholar
• Lewellyn EB, Loeb DD. Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus. J Virol. 2007 Jun;81(12):6207–6215. DOI:10.1128/JVI.00210-07.
   PubMed Web of Science ®Google Scholar
• Xu Z, Ou JH. Endogenous polymerase assay for the analysis of hepatitis B virus in transgenic mice. Methods Mol Med. 2004;95:295–302.
   PubMedGoogle Scholar
• Yang W, Summers J. Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor. J Virol. 1999 Dec;73(12):9710–9717. DOI:10.1128/JVI.73.12.9710-9717.1999.
   PubMed Web of Science ®Google Scholar
• Tu T, Zhang H, Urban S. Hepatitis B virus DNA integration: in vitro models for investigating viral pathogenesis and persistence. Viruses. 2021 Jan 26;13(2):2. DOI:10.3390/v13020180.
   Web of Science ®Google Scholar
• Ko C, Chakraborty A, Chou WM, et al. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels. J Hepatol. 2018;69(6):1231–1241. 12. DOI:10.1016/j.jhep.2018.08.012.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Zhang BH, Theele D, et al. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci U S A. 2003 Oct;100(21):12372–12377. DOI:10.1073/pnas.2033898100.
   PubMed Web of Science ®Google Scholar
• Summers J, Smith PM, Horwich AL. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol. 1990 Jun;64(6):2819–2824. DOI:10.1128/JVI.64.6.2819-2824.1990.
   PubMed Web of Science ®Google Scholar
• Lentz TB, Loeb DD. Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus. J Virol. 2011 Nov;85(22):11916–11927. DOI:10.1128/JVI.05373-11.
   PubMed Web of Science ®Google Scholar
• Kamimura T, Yoshikawa A, Ichida F, et al. Electron microscopic studies of Dane particles in hepatocytes with special reference to intracellular development of Dane particles and their relation with HBeAg in serum. Hepatology. 1981 Sep-Oct;1(5):392–397. DOI:10.1002/hep.1840010504.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Sorensen EM, Naito A, et al. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci U S A. 2007 Jun;104(24):10205–10210. DOI:10.1073/pnas.0704000104.
   PubMed Web of Science ®Google Scholar
• Stieler JT, Prange R. Involvement of ESCRT-II in hepatitis B virus morphogenesis. PLoS One. 2014;9(3):e91279.
   PubMed Web of Science ®Google Scholar
• Hoffmann J, Boehm C, Himmelsbach K, et al. Identification of α-taxilin as an essential factor for the life cycle of hepatitis B virus. J Hepatol. 2013 Nov;59(5):934–941. DOI:10.1016/j.jhep.2013.06.020.
   PubMed Web of Science ®Google Scholar
• Rost M, Mann S, Lambert C, et al. Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation. J Biol Chem. 2006 Sep;281(39):29297–29308. DOI:10.1074/jbc.M603517200.
   PubMed Web of Science ®Google Scholar
• Lambert C, Döring T, Prange R. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol. 2007 Sep;81(17):9050–9060. DOI:10.1128/JVI.00479-07.
   PubMed Web of Science ®Google Scholar
• Li J, Liu Y, Wang Z, et al. Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment. J Virol. 2011 Jul;85(13):6319–6333. DOI:10.1128/JVI.02627-10.
   PubMed Web of Science ®Google Scholar
• Inoue J, Krueger EW, Chen J, et al. HBV secretion is regulated through the activation of endocytic and autophagic compartments mediated by Rab7 stimulation. J Cell Sci. 2015 May;128(9):1696–1706. DOI:10.1242/jcs.158097.
   PubMed Web of Science ®Google Scholar
• Bartusch C, Döring T, Prange R. Rab33B controls Hepatitis B virus assembly by regulating core membrane association and nucleocapsid processing. Viruses. 2017;9(6). 10.3390/v9060157.
   PubMed Web of Science ®Google Scholar
• Inoue J, Ninomiya M, Umetsu T, et al. Small interfering RNA screening for the small gtpase rab proteins identifies Rab5B as a major regulator of Hepatitis b virus production. J Virol.2019 08;93(15). 10.1128/JVI.00621-19.
   PubMed Web of Science ®Google Scholar
• Patzer EJ, Nakamura GR, Simonsen CC, et al. Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol. 1986 Jun;58(3):884–892. DOI:10.1128/JVI.58.3.884-892.1986.
   PubMed Web of Science ®Google Scholar
• Huovila AP, Eder AM, Fuller SD. Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol. 1992 Sep;118(6):1305–1320. DOI:10.1083/jcb.118.6.1305.
   PubMed Web of Science ®Google Scholar
• Zeyen L, Döring T, Stieler JT, et al. Hepatitis B subviral envelope particles use the COPII machinery for intracellular transport via selective exploitation of Sec24A and Sec23B. Cell Microbiol. 2020 06;22(6):e13181. DOI:10.1111/cmi.13181.
   PubMed Web of Science ®Google Scholar
• Bardens A, Döring T, Stieler J, et al. Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner. Cell Microbiol Apr. 2011;13(4):602–619.
   PubMed Web of Science ®Google Scholar
• Döring T, Prange R. Rab33B and its autophagic Atg5/12/16L1 effector assist in hepatitis B virus naked capsid formation and release. Cell Microbiol. 2015 May;17(5):747–764. DOI:10.1111/cmi.12398.
   PubMed Web of Science ®Google Scholar
• Qiao L, Luo GG. Human apolipoprotein E promotes hepatitis B virus infection and production. PLoS Pathog. 2019 Aug;15(8):e1007874. DOI:10.1371/journal.ppat.1007874.
   PubMed Web of Science ®Google Scholar
• Zhu RX, Seto WK, Lai CL, et al. Epidemiology of hepatocellular carcinoma in the Asia-Pacific Region. Rev Gut Liver. 2016 May 23;10(3):332–339. DOI:10.5009/gnl15257.
   PubMed Web of Science ®Google Scholar
• Rapti I, Hadziyannis S. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues. Review World J Hepatol. 2015 May 18;7(8):1064–1073. DOI:10.4254/wjh.v7.i8.1064.
   PubMedGoogle Scholar
• Tseng TC, Liu CJ, Yang HC, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. research support, Non-U.S. Gov’t. Gastroenterology. 2012 May;142(5):1140–1149 e3; quiz e13-4. DOI:10.1053/j.gastro.2012.02.007.
   Web of Science ®Google Scholar
• Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. research support, Non-U.S. Gov’t. N Engl J Med. 2002 Jul 18;347(3):168–174. DOI:10.1056/NEJMoa013215.
   PubMed Web of Science ®Google Scholar
• Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. multicenter study research support, Non-U.S. Gov’t. Clin Gastroenterol Hepatol. 2007 Aug;5(8):921–931. DOI:10.1016/j.cgh.2007.06.015.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. research support, Non-U.S. Gov’t. JAMA. 2006 Jan 4;295(1):65–73. DOI:10.1001/jama.295.1.65.
   PubMed Web of Science ®Google Scholar
• Wu JC, Huang YH, Chau GY, et al. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. research support, Non-U.S. Gov’t J Hepatol. 2009 Nov;51(5):890–897. DOI:10.1016/j.jhep.2009.07.009.
   PubMed Web of Science ®Google Scholar
• Hung IF, Poon RT, Lai CL, et al. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am J Gastroenterol. 2008 Jul;103(7):1663–1673. DOI:10.1111/j.1572-0241.2008.01872.x.
   PubMed Web of Science ®Google Scholar
• Wang SH, Chen PJ, Yeh SH. Gender disparity in chronic hepatitis B: mechanisms of sex hormones. J Gastroenterol Hepatol. 2015 Aug;30(8):1237–1245. DOI:10.1111/jgh.12934.
   PubMed Web of Science ®Google Scholar
• Na B, Huang Z, Wang Q, et al. Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury. PLoS One. 2011;6(10):e26240.
   PubMed Web of Science ®Google Scholar
• Yang WJ, Chang CJ, Yeh SH, et al. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways. Hepatology. 2009 May;49(5):1515–1524. DOI:10.1002/hep.22833.
   PubMed Web of Science ®Google Scholar
• Wu MH, Ma WL, Hsu CL, et al. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med. 2010 May 19;2(32):32ra35. DOI:10.1126/scitranslmed.3001143.
   PubMed Web of Science ®Google Scholar
• Brechot C, Pourcel C, Louise A, et al. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. case reports. Nature. 1980 Jul 31;286(5772):533–535. DOI:10.1038/286533a0.
   PubMed Web of Science ®Google Scholar
• Zhao LH, Liu X, Yan HX, et al. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. research support, Non-U.S. Gov’t.Nature communications.2016 Oct 5;7:12992. DOI:10.1038/ncomms12992.
   PubMed Web of Science ®Google Scholar
• Peng Z, Zhang Y, Gu W, et al. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Research Support, Non-U S Gov’t Int J Oncol. 2005 Feb;26(2):467–473.
   Google Scholar
• Ma NF, Lau SH, Hu L, et al. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. research support, Non-U.S. Gov’t. Clin Cancer Res off J Am Assoc Cancer Res. 2008 Aug 15;14(16):5061–5068. DOI:10.1158/1078-0432.CCR-07-5082.
   PubMed Web of Science ®Google Scholar
• Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Review. Gastroenterology. 2004 Nov;127(5 Suppl 1):S56–61. DOI:10.1053/j.gastro.2004.09.016.
   PubMed Web of Science ®Google Scholar
• Lee J, Tsai KN, Ou JJ. Mechanisms of Hepatitis B virus-induced hepatocarcinogenesis. Recent Results Cancer Res. 2021;217:47–70.
   PubMedGoogle Scholar
• Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype j. research support, Non-U.S.Gov’t. J Virol. 2009 Oct;83(20):10538–10547. DOI:10.1128/JVI.00462-09.
   PubMed Web of Science ®Google Scholar
• Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. Review. World J Gastroenterol. 2014 May 14;20(18):5427–5434. DOI:10.3748/wjg.v20.i18.5427.
   PubMed Web of Science ®Google Scholar
• Shi W, Zhu C, Zheng W, et al. Subgenotyping of genotype C hepatitis B virus: correcting misclassifications and identifying a novel subgenotype. research support, Non-U.S. Gov’t. PLoS One. 2012;7(10):e47271.
   PubMed Web of Science ®Google Scholar
• Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. review. J Gastroenterol Hepatol. 2011 Jan;26(1):123–130. DOI:10.1111/j.1440-1746.2010.06541.x.
   PubMedGoogle Scholar
• Erhardt A, Blondin D, Hauck K, et al. Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Research Support, Non-U.S. Gov’t . Gut. 2005 Jul;54(7):1009–1013. DOI:10.1136/gut.2004.060327.
   PubMed Web of Science ®Google Scholar
• Janssen HL, van Zonneveld M, Senturk H, et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. clinical trial multicenter study randomized controlled trial research support, Non-U.S. Gov’t. Lancet. 2005 Jan 8-14;365(9454):123–129. DOI:10.1016/S0140-6736(05)17701-0.
   PubMed Web of Science ®Google Scholar
• Kao JH, Wu NH, Chen PJ, et al. Hepatitis B genotypes and the response to interferon therapy. research support, Non-U.S. Gov’t. J Hepatol. 2000 Dec;33(6):998–1002. DOI:10.1016/s0168-8278(00)80135-x.
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Isogawa M, Chisari FV. Host-virus interactions in hepatitis B virus infection. research support, N.I.H., extramural research support, Non-U.S. Gov’t Review. Curr Opin Immunol. 2015Oct;36:61–66. DOI:10.1016/j.coi.2015.06.016.
   PubMed Web of Science ®Google Scholar
• Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. editorial. World J Gastroenterol. 2009 Dec 14;15(46):5761–5769. DOI:10.3748/wjg.15.5761.
   PubMed Web of Science ®Google Scholar
• Oommen PT, Wirth S, Wintermeyer P, et al. Relationship between viral load and genotypes of hepatitis B virus in children with chronic hepatitis B. J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):342–347. DOI:10.1097/01.mpg.0000233191.95447.1e.
   PubMed Web of Science ®Google Scholar
• Thakur V, Guptan RC, Kazim SN, et al. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol. 2002 Feb;17(2):165–170. DOI:10.1046/j.1440-1746.2002.02605.x.
   PubMed Web of Science ®Google Scholar
• Verschuere V, Yap PS, Fevery J. Is HBV genotyping of clinical relevance? comparative study review. Acta Gastroenterol Belg. 2005 Apr-Jun;68(2):233–236.
   PubMed Web of Science ®Google Scholar
• Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. Research Support, Non-U.S. Gov’t. J Natl Cancer Inst. 2008 Aug 20;100(16):1134–1143. DOI:10.1093/jnci/djn243.
   PubMedGoogle Scholar
• Zollner B, Petersen J, Puchhammer-Stockl E, et al. Viral features of lamivudine resistant hepatitis B genotypes A and D. research support, Non-U.S. Gov’t. Hepatology. 2004 Jan;39(1):42–50. DOI:10.1002/hep.20016.
   PubMed Web of Science ®Google Scholar
• Kao JH. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. research support, Non-U.S. Gov’t review. Intervirology. 2003;46(6):400–407.
   PubMed Web of Science ®Google Scholar
• Yin J, Zhang H, Li C, et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. research support, Non-U.S. Gov’t. Carcinogenesis. 2008 Sep;29(9):1685–1691. DOI:10.1093/carcin/bgm301.
   PubMed Web of Science ®Google Scholar
• Park SG, Kim Y, Park E, et al. Fidelity of hepatitis B virus polymerase. comparative study research support, Non-U.S. Gov’t. Eur J Biochem. 2003 Jul;270(14):2929–2936. DOI:10.1046/j.1432-1033.2003.03650.x.
   PubMedGoogle Scholar
• Caligiuri P, Cerruti R, Icardi G, et al. Overview of hepatitis B virus mutations and their implications in the management of infection. review. World J Gastroenterol. 2016 Jan 7;22(1):145–154. DOI:10.3748/wjg.v22.i1.145.
   PubMed Web of Science ®Google Scholar
• Buckwold VE, Xu Z, Chen M, et al. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S. J Virol. 1996 Sep;70(9):5845–5851. DOI:10.1128/JVI.70.9.5845-5851.1996.
   PubMed Web of Science ®Google Scholar
• Hunt CM, McGill JM, Allen MI, et al. Clinical relevance of hepatitis B viral mutations. Research Support, Non-U.S. Gov’t Review. Hepatology. 2000 May;31(5):1037–1044. DOI:10.1053/he.2000.6709.
   PubMed Web of Science ®Google Scholar
• Li J, Buckwold VE, Hon MW, et al. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. J Virol. 1999 Feb;73(2):1239–1244. DOI:10.1128/JVI.73.2.1239-1244.1999.
   PubMed Web of Science ®Google Scholar
• Kosaka Y, Takase K, Kojima M, et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology. 1991 Apr;100(4):1087–1094. DOI:10.1016/0016-5085(91)90286-t.
   PubMed Web of Science ®Google Scholar
• Liang TJ, Hasegawa K, Rimon N, et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. Research Support, U.S. Gov’t, P.H.S. N Engl J Med. 1991 Jun 13;324(24):1705–1709. DOI:10.1056/NEJM199106133242405.
   PubMed Web of Science ®Google Scholar
• Ou JH. Molecular biology of hepatitis B virus e antigen. Research Support, Non-U.S. Gov’t Review. J Gastroenterol Hepatol. 1997 Oct;12(9–10):S178–87. DOI:10.1111/j.1440-1746.1997.tb00499.x.
   PubMed Web of Science ®Google Scholar
• Yeh CT, So M, Ng J, et al. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Research Support, Non-U.S. Gov’t. Hepatology. 2010 Dec;52(6):1922–1933. DOI:10.1002/hep.23898.
   PubMed Web of Science ®Google Scholar
• Liu CJ, Chen BF, Chen PJ, et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. Research Support, Non-U.S. Gov’t. J Infect Dis. 2006 May 1;193(9):1258–1265. DOI:10.1086/502978.
   PubMed Web of Science ®Google Scholar
• Kao JH, Chen PJ, Lai MY, et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Research Support, Non-U.S. Gov’t. Gastroenterology. 2003 Feb;124(2):327–334. DOI:10.1053/gast.2003.50053.
   PubMed Web of Science ®Google Scholar
• Yan J, Yao Z, Hu K, et al. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53. Research Support, Non-U.S. Gov’t. Dig Dis Sci. 2015 May;60(5):1315–1324. DOI:10.1007/s10620-014-3492-9.
   PubMed Web of Science ®Google Scholar
• Kwun HJ, Jang KL. Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Research Support, Non-U.S. Gov’t. Nucleic Acids Res. 2004;32(7):2202–2213.
   PubMed Web of Science ®Google Scholar
• Muroyama R, Kato N, Yoshida H, et al. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. Research Support, Non-U.S. Gov’t. J Hepatol. 2006 Dec;45(6):805–812. DOI:10.1016/j.jhep.2006.07.025.
   PubMed Web of Science ®Google Scholar
• Pollicino T, Cacciola I, Saffioti F, et al. Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications. Research Support, Non-U.S. Gov’t Review. J Hepatol. 2014 Aug;61(2):408–417. DOI:10.1016/j.jhep.2014.04.041.
   PubMed Web of Science ®Google Scholar
• Su IJ, Wang LH, Hsieh WC, et al. The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis. Research Support, Non-U.S. Gov’t Review. J Biomed Sci. 2014;21:98. DOI:10.1186/s12929-014-0098-7.
   PubMed Web of Science ®Google Scholar
• Chen BF, Liu CJ, Jow GM, et al. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Research Support, Non-U.S. Gov’t. Gastroenterology. 2006 Apr;130(4):1153–1168. DOI:10.1053/j.gastro.2006.01.011.
   PubMed Web of Science ®Google Scholar
• Wang HC, Wu HC, Chen CF, et al. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Research Support, Non-U.S. Gov’t. Am J Pathol. 2003 Dec;163(6):2441–2449. DOI:10.1016/S0002-9440(10)63599-7.
   PubMed Web of Science ®Google Scholar
• Xu Z, Yen TS. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J Virol. 1996 Jan;70(1):133–140. DOI:10.1128/JVI.70.1.133-140.1996.
   PubMed Web of Science ®Google Scholar
• Raimondo G, Costantino L, Caccamo G, et al. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. J Hepatol. 2004 Mar;40(3):515–519. DOI:10.1016/j.jhep.2003.11.025.
   PubMed Web of Science ®Google Scholar
• Wu Y, Gan Y, Gao F, et al. Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t PloS One. 2014;9(5):e94864.
   PubMed Web of Science ®Google Scholar
• Yin F, Xie Y, Fan H, et al. Mutations in hepatitis B virus polymerase are associated with the postoperative survival of hepatocellular carcinoma patients. PloS One. 2017;12(12):e0189730.
   PubMed Web of Science ®Google Scholar
• Gunther S, Sommer G, Iwanska A, et al. Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA. Research Support, Non-U.S. Gov’t. Virology. 1997 Nov 24;238(2):363–371. DOI:10.1006/viro.1997.8863.
   PubMed Web of Science ®Google Scholar
• Su TS, Lai CJ, Huang JL, et al. Hepatitis B virus transcript produced by RNA splicing. Research Support, Non-U.S. Gov’t. J Virol. 1989 Sep;63(9):4011–4018. DOI:10.1128/JVI.63.9.4011-4018.1989.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kajino K, Masui N, et al. Alternative splicing of hepatitis B virus RNAs in HepG2 cells transfected with the viral DNA. Research Support, Non-U.S. Gov’t. Virology. 1990 Dec;179(2):881–885. DOI:10.1016/0042-6822(90)90160-s.
   PubMed Web of Science ®Google Scholar
• Choo KB, Liew LN, Chong KY, et al. Transgenome transcription and replication in the liver and extrahepatic tissues of a human hepatitis B virus transgenic mouse. Research Support, Non-U.S. Gov’t. Virology. 1991 Jun;182(2):785–792. DOI:10.1016/0042-6822(91)90619-m.
   PubMed Web of Science ®Google Scholar
• Wu HL, Chen PJ, Tu SJ, et al. Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells. Research Support, Non-U.S. Gov’t. J Virol. 1991 Apr;65(4):1680–1686. DOI:10.1128/JVI.65.4.1680-1686.1991.
   PubMed Web of Science ®Google Scholar
• Chen PJ, Chen CR, Sung JL, et al. Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus. Research Support, Non-U.S. Gov’t. J Virol. 1989 Oct;63(10):4165–4171. DOI:10.1128/JVI.63.10.4165-4171.1989.
   PubMed Web of Science ®Google Scholar
• Huang CC, Kuo TM, Yeh CT, et al. One single nucleotide difference alters the differential expression of spliced RNAs between HBV genotypes A and D. Comparative Study Research Support, Non-U.S. Gov’t. Virus Res. 2013 Jun;174(1–2):18–26. DOI:10.1016/j.virusres.2013.02.004.
   PubMed Web of Science ®Google Scholar
• Sommer G, van Bommel F, Will H. Genotype-specific synthesis and secretion of spliced hepatitis B virus genomes in hepatoma cells. Research Support, Non-U.S. Gov’t. Virology. 2000 Jun 5;271(2):371–381. DOI:10.1006/viro.2000.0331.
   PubMed Web of Science ®Google Scholar
• Betz-Stablein BD, Topfer A, Littlejohn M, et al. Single-molecule sequencing reveals complex genome variation of Hepatitis B virus during 15 years of chronic infection following liver transplantation. Research Support, Non-U.S. Gov’t. J Virol. 2016 Aug 15;90(16):7171–7183. DOI:10.1128/JVI.00243-16.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu M, Wang F, et al. Hepatitis B virus spliced variants are associated with an impaired response to interferon therapy. Research Support, Non-U.S. Gov’t. Sci Rep. 2015;5:16459. DOI:10.1038/srep16459.
   PubMed Web of Science ®Google Scholar
• Terre S, Petit MA, Brechot C. Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo. J Virol. 1991 Oct;65(10):5539–5543. DOI:10.1128/JVI.65.10.5539-5543.1991.
   PubMed Web of Science ®Google Scholar
• Tsai KN, Chong CL, Chou YC, et al. Doubly spliced RNA of Hepatitis b virus suppresses viral transcription via TATA-binding protein and induces stress granule assembly. Research Support, Non-U.S. Gov’t. J Virol. 2015 Nov;89(22):11406–11419. DOI:10.1128/JVI.00949-15.
   PubMed Web of Science ®Google Scholar
• Soussan P, Tuveri R, Nalpas B, et al. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. Research Support, Non-U.S. Gov’t. J Hepatol. 2003 Mar;38(3):343–348. DOI:10.1016/s0168-8278(02)00422-1.
   PubMed Web of Science ®Google Scholar
• Mancini-Bourgine M, Bayard F, Soussan P, et al. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. Research Support, Non-U.S. Gov’t. J Virol. 2007 May;81(10):4963–4972. DOI:10.1128/JVI.02619-06.
   PubMed Web of Science ®Google Scholar
• Pol JG, Lekbaby B, Redelsperger F, et al. Alternative splicing-regulated protein of hepatitis B virus hacks the TNF-alpha-stimulated signaling pathways and limits the extent of liver inflammation. Research Support, Non-U.S. Gov’t. FASEB J. 2015 May;29(5):1879–1889. DOI:10.1096/fj.14-258715.
   PubMed Web of Science ®Google Scholar
• Wu SX, Chen WN, Jing ZT, et al. Hepatitis B spliced protein (HBSP) suppresses fas-mediated hepatocyte apoptosis via activation of PI3K/Akt Signaling. Research Support, Non-U.S. Gov’t. J Virol. 2018;92(23). DOI:10.1128/JVI.01273-18.
   Web of Science ®Google Scholar
• Wang YL, Liou GG, Lin CH, et al. The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation. Research Support, Non-U.S. Gov’t. PLoS One. 2015;10(3):e0119625.
   PubMed Web of Science ®Google Scholar
• Duriez M, Mandouri Y, Lekbaby B, et al. Alternative splicing of hepatitis B virus: a novel virus/host interaction altering liver immunity. Research Support, Non-U.S. Gov’t. J Hepatol. 2017 Oct;67(4):687–699. DOI:10.1016/j.jhep.2017.05.025.
   PubMed Web of Science ®Google Scholar
• Kremsdorf D, Soussan P, Paterlini-Brechot P, et al. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Review. Oncogene. 2006 Jun 26;25(27):3823–3833. DOI:10.1038/sj.onc.1209559.
   PubMed Web of Science ®Google Scholar
• Lin X, Wen Y, Wan D, et al. [Structural and functional analysis of 2.2 kb spliced variant of hepatitis B virus genomes isolated from liver tissues from hepatocellular carcinoma patients]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 2002 Mar;16(1):11–15.
   PubMedGoogle Scholar
• Bayliss J, Lim L, Thompson AJ, et al. Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma. Research Support, Non-U.S. Gov’t. J Hepatol. 2013 Nov;59(5):1022–1028. DOI:10.1016/j.jhep.2013.06.018.
   PubMed Web of Science ®Google Scholar
• Kremsdorf D, Lekbaby B, Bablon P, et al. Alternative splicing of viral transcripts: the dark side of HBV. Gut. 2021 Sep 17. DOI:10.1136/gutjnl-2021-324554.
   PubMed Web of Science ®Google Scholar
• Asabe S, Wieland SF, Chattopadhyay PK, et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov’t. J Virol. 2009 Oct;83(19):9652–9662. DOI:10.1128/JVI.00867-09.
   PubMedGoogle Scholar
• Tian Y, Chen WL, Ou JH. Effects of interferon-alpha/beta on HBV replication determined by viral load. Research Support, N.I.H., Extramural. PLoS Pathog. 2011 Jul;7(7):e1002159. DOI:10.1371/journal.ppat.1002159.
   PubMed Web of Science ®Google Scholar
• Tian Y, Chen WL, Kuo CF, et al. Viral-load-dependent effects of liver injury and regeneration on hepatitis B virus replication in mice. Research Support, N.I.H., Extramural. J Virol. 2012 Sep;86(18):9599–9605. DOI:10.1128/JVI.01087-12.
   PubMed Web of Science ®Google Scholar
• Bonvin M, Achermann F, Greeve I, et al. Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology. 2006;43(6):1364–1374.
   PubMed Web of Science ®Google Scholar
• Noguchi C, Hiraga N, Mori N, et al. Dual effect of APOBEC3G on Hepatitis B virus. J Gen Virol. 2007;88(2):432–440.
   PubMedGoogle Scholar
• Turelli P, Mangeat B, Jost S, et al. Inhibition of hepatitis B virus replication by APOBEC3G. Science. 2004 Mar;303(5665):1829. DOI:10.1126/science.1092066.
   PubMed Web of Science ®Google Scholar
• Nguyen DH, Gummuluru S, Hu J. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J Virol. 2007 May;81(9):4465–4472. DOI:10.1128/JVI.02510-06.
   PubMed Web of Science ®Google Scholar
• Chen H, Wang L-W, Huang Y-Q, et al. Interferon-alpha induces high expression of APOBEC3G and STAT-1 in vitro and in vivo. Int J Mol Sci. 2010;11(9):3501–3512.
   PubMed Web of Science ®Google Scholar
• Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Research Support, N.I.H., Extramural Review. Pathol Biol. 2010 Aug;58(4):258–266. DOI:10.1016/j.patbio.2009.11.001.
   PubMedGoogle Scholar
• Said ZN, Abdelwahab KS. Induced immunity against hepatitis B virus. World J Hepatol. 2015 Jun 28;7(12):1660–1670. DOI:10.4254/wjh.v7.i12.1660.
   PubMed Web of Science ®Google Scholar
• Rehermann B, Fowler P, Sidney J, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. J Exp Med. 1995 Mar 1;181(3):1047–1058. DOI:10.1084/jem.181.3.1047.
   PubMed Web of Science ®Google Scholar
• Reignat S, Webster GJ, Brown D, et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. Research Support, Non-U.S. Gov’t. J Exp Med. 2002 May 6;195(9):1089–1101. DOI:10.1084/jem.20011723.
   PubMed Web of Science ®Google Scholar
• Maini MK, Schurich A. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J Hepatol. 2010 Apr;52(4):616–619. DOI:10.1016/j.jhep.2009.12.017.
   PubMed Web of Science ®Google Scholar
• Fisicaro P, Barili V, Rossi M, et al. Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches. Research Support, Non-U.S. Gov’t Review. Front Immunol. 2020;11:849.
   PubMed Web of Science ®Google Scholar
• Ye B, Liu X, Li X, et al. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Research Support, Non-U.S. Gov’t Review. Cell Death Dis. 2015 Mar 19;6: e1694. DOI:10.1038/cddis.2015.42.
   PubMed Web of Science ®Google Scholar
• Bengsch B, Martin B, Thimme R. Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. Comparative Study Research Support, Non-U.S. Gov’t. J Hepatol. 2014 Dec;61(6):1212–1219. DOI:10.1016/j.jhep.2014.07.005.
   PubMed Web of Science ®Google Scholar
• Wenjin Z, Chuanhui P, Yunle W, et al. Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B. BMC Gastroenterol. 2012 Aug 16;12: 109. DOI:10.1186/1471-230X-12-109.
   PubMed Web of Science ®Google Scholar
• Maier H, Isogawa M, Freeman GJ, et al. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t. J Immunol. 2007 Mar 1;178(5):2714–2720. DOI:10.4049/jimmunol.178.5.2714.
   PubMed Web of Science ®Google Scholar
• Chapoval AI, Ni J, Lau JS, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S. Nat Immunol. 2001 Mar;2(3):269–274. DOI:10.1038/85339.
   PubMed Web of Science ®Google Scholar
• Luan Y, Ju J, Luo L, et al. Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection. Research Support, Non-U.S. Gov’t. J Viral Hepat. 2012 Jan;19(1):23–31. DOI:10.1111/j.1365-2893.2010.01421.x.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tian Z. HBV-Induced Immune Imbalance in the Development of HCC. Research Support, Non-U.S. Gov’t Review. Front Immunol. 2019;10:2048.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao W, Cheng L, et al. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t. J Immunol. 2010 Dec 15;185(12):7654–7662. DOI:10.4049/jimmunol.1000927.
   PubMed Web of Science ®Google Scholar
• Bortolotti F, Realdi G, Diodati G, et al. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis. Clin Exp Immunol. 1978 Aug;33(2):211–216.
   PubMed Web of Science ®Google Scholar
• Thomson AD, Cochrane MA, McFarlane IG, et al. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature. 1974 Dec 20;252(5485):721–722. DOI:10.1038/252721a0.
   PubMed Web of Science ®Google Scholar
• Cochrane AM, Moussouros A, Thomsom AD, et al. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet. 1976 Feb 28;1(7957):441–444. DOI:10.1016/s0140-6736(76)91472-0.
   PubMed Web of Science ®Google Scholar
• Cochrane AM, Moussouros A, Smith A, et al. Autoimmune reaction to a liver specific membrane antigen during acute viral hepatitis. Gut. 1976 Sep;17(9):714–718. DOI:10.1136/gut.17.9.714.
   PubMed Web of Science ®Google Scholar
• van Erp EA, Luytjes W, Ferwerda G, et al. Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease. Research Support, Non-U.S. Gov’t Review. Front Immunol. 2019;10:548. DOI:10.3389/fimmu.2019.00548
   PubMedGoogle Scholar
• Ray MB, Desmet VJ, Bradburne AF, et al. Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology. 1976 Sep;71(3):462–469.
   PubMed Web of Science ®Google Scholar
• Saito T, Kamimura T, Ishibashi M, et al. Electron microscopic study of hepatitis B virus-associated antigens on the infected liver cell membrane in relation to analysis of immune target antigens in chronic hepatitis B. Gastroenterol Jpn. 1992 Dec;27(6):734–744. DOI:10.1007/BF02806526.
   PubMedGoogle Scholar
• Trevisan A, Realdi G, Alberti A, et al. Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. Gastroenterology. 1982 Feb;82(2):218–222.
   PubMed Web of Science ®Google Scholar
• Michalak TI, Lau JY, McFarlane BM, et al. Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B. Clin Exp Immunol. 1995 May;100(2):227–232. DOI:10.1111/j.1365-2249.1995.tb03658.x.
   PubMed Web of Science ®Google Scholar
• Gill US, Golden-Mason L. HCMV jogs the ‘memory’ of NK cells in HBV. editorial research support, N.I.H., extramural Research Support, Non-U.S. Gov’t Comment. J Hepatol. 2019 Mar;70(3):343–345. DOI:10.1016/j.jhep.2018.11.009.
   PubMedGoogle Scholar
• Yu WH, Cosgrove C, Berger CT, et al. ADCC-mediated CD56(DIM) NK cell responses are associated with early hbsag clearance in acute HBV infection. Pathog Immun. 2018;3(1):2–18.
   PubMedGoogle Scholar
• Peng H, Wisse E, Tian Z. Liver natural killer cells: subsets and roles in liver immunity. Review Research Support, Non-U.S. Gov’t. Cell Mol Immunol. 2016 May;13(3):328–336. DOI:10.1038/cmi.2015.96.
   PubMed Web of Science ®Google Scholar
• Racanelli V, Rehermann B. The liver as an immunological organ. Research Support, N.I.H., Intramural Review. Hepatology. 2006 Feb;43(2Suppl 1):S54–62. DOI:10.1002/hep.21060.
   PubMedGoogle Scholar
• Zheng M, Sun R, Wei H, et al. NK cells help induce anti-Hepatitis B virus CD8+ T cell immunity in mice. J Immunol. 2016 May 15;196(10):4122–4131. DOI:10.4049/jimmunol.1500846.
   PubMed Web of Science ®Google Scholar
• Marotel M, Villard M, Drouillard A, et al. Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion. Elife. 2021 Jan 28;10. DOI:10.7554/eLife.60095.
   Web of Science ®Google Scholar
• Tjwa ET, van Oord GW, Hegmans JP, et al. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol. 2011 Feb;54(2):209–218. DOI:10.1016/j.jhep.2010.07.009.
   PubMed Web of Science ®Google Scholar
• Sun C, Fu B, Gao Y, et al. TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. Research Support, Non-U.S. Gov’t. PLoS Pathog. 2012;8(3):e1002594.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang S, Zou Z, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Research Support, Non-U.S. Gov’t. Hepatology. 2011 Jan;53(1):73–85. DOI:10.1002/hep.23977.
   PubMed Web of Science ®Google Scholar
• Peppa D, Micco L, Javaid A, et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. Research Support, Non-U.S. Gov’t. PLoS Pathog. 2010 Dec 16;6(12):e1001227. DOI:10.1371/journal.ppat.1001227.
   PubMed Web of Science ®Google Scholar
• Long EO, Kim HS, Liu D, et al. Controlling natural killer cell responses: integration of signals for activation and inhibition. Research Support, N.I.H., Intramural Review. Annu Rev Immunol. 2013;31:227–258.
   PubMed Web of Science ®Google Scholar
• Peppa D, Gill US, Reynolds G, et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. Research Support, Non-U.S. Gov’t. J Exp Med. 2013 Jan 14;210(1):99–114. DOI:10.1084/jem.20121172.
   PubMed Web of Science ®Google Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review. Nat Rev Immunol. 2008 Jul;8(7):523–532. DOI:10.1038/nri2343.
   PubMed Web of Science ®Google Scholar
• Fu J, Xu D, Liu Z, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Research Support, Non-U.S. Gov’t. Gastroenterology. 2007 Jun;132(7):2328–2339. DOI:10.1053/j.gastro.2007.03.102.
   PubMed Web of Science ®Google Scholar
• Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. Research Support, Non-U.S. Gov’t. J Immunol. 2006 Jul 1;177(1):739–747. DOI:10.4049/jimmunol.177.1.739.
   PubMed Web of Science ®Google Scholar
• Park JJ, Wong DK, Wahed AS, et al. Hepatitis B virus–specific and global t-cell dysfunction in chronic Hepatitis B. multicenter study Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Gastroenterology. 2016 Mar;150(3):684–695e5. DOI:10.1053/j.gastro.2015.11.050.
   PubMed Web of Science ®Google Scholar
• Ma Q, Dong X, Liu S, et al. Hepatitis B e Antigen Induces NKG2A(+) Natural Killer Cell Dysfunction via Regulatory T Cell-Derived Interleukin 10 in Chronic Hepatitis B Virus Infection. Front Cell Dev Biol. 2020;8:421.
   PubMed Web of Science ®Google Scholar
• Duarte N, Coelho IC, Patarrao RS, et al. How inflammation impinges on NAFLD: a role for kupffer cells. Biomed Res Int. 2015;2015:984578.
   PubMed Web of Science ®Google Scholar
• Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Research Support, Non-U.S. Gov’t. Immunity. 2013 Jan 24;38(1):79–91. DOI:10.1016/j.immuni.2012.12.001.
   PubMed Web of Science ®Google Scholar
• Sitia G, Iannacone M, Aiolfi R, et al. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t. PLoS Pathog. 2011 Jun;7(6):e1002061. DOI:10.1371/journal.ppat.1002061.
   PubMed Web of Science ®Google Scholar
• Wu LL, Peng WH, Wu HL, et al. Lymphocyte antigen 6 complex, locus C(+) monocytes and kupffer cells orchestrate liver immune responses against Hepatitis B virus in mice. Research Support, Non-U.S. Gov’t. Hepatology. 2019 Jun;69(6):2364–2380. DOI:10.1002/hep.30510.
   PubMed Web of Science ®Google Scholar
• Li M, Sun R, Xu L, et al. Kupffer cells support hepatitis b virus-mediated cd8+ t cell exhaustion via hepatitis b core antigen-tlr2 interactions in mice. Research Support, Non-U.S. Gov’t. J Immunol. 2015 Oct 1;195(7):3100–3109. DOI:10.4049/jimmunol.1500839.
   PubMed Web of Science ®Google Scholar
• Bility MT, Cheng L, Zhang Z, et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. Research Support, N.I.H., extramural Research Support, Non-U.S. Gov’t. PLoS Pathog. 2014 Mar;10(3):e1004032. DOI:10.1371/journal.ppat.1004032.
   PubMed Web of Science ®Google Scholar